Abstract
This retrospective study has aimed at determining the prevalence, aetiology and clinical evolution of chronic liver disease (CLD) after allogeneic bone marrow transplantation (BMT). A total of 106 patients who had been transplanted in a single institution and who had survived for at least 2 years after BMT were studied. The prevalence of CLD was 57.5% (61/106). In 47.3% of cases more than one aetiopathogenic agent coexisted. The causes of CLD were iron overload (52.4%), chronic hepatitis C (47.5%), chronic graft-versus-host disease (C-GVHD) (37.7%), hepatitis B (6.5%), non-alcoholic steatohepatitis (NASH) (4.9%), autoimmune hepatitis (AIH) (4.9%) and unknown two (3.3%). Twenty-three patients with iron overload underwent venesections which were well tolerated. An improvement in liver function tests (LFTs) was observed in 21 (91%) patients. All six patients with siderosis as the only cause of CLD normalized LFT as well as three patients with HCV infection. Clinical evolution was satisfactory for patients with GVHD, AIH, NASH and hepatitis B. At the last visit 23 patients continued with abnormal LFTs, and 19 of them were infected by the HCV. A sustained biochemical and virologic response was achieved in only one case out of six patients with CHC who received interferon. We have found that CLD is a common complication in long-term BMT survivors. The aetiology is often multifactorial, iron overload, CHC and C-GVHD being the main causes. The CLD followed a rather ‘benign’ and slow course in our patients as none of them developed symptoms or signs of liver failure and we did not observe an increase in morbidity or mortality in these patients, but a longer follow-up is necessary in HCV infected patients based on the natural history of this infection in other populations. Bone Marrow Transplantation (2000) 26, 649–655.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McDonald GB, Shulman HM, Wolford JL, Spencer GD . Liver disease after human marrow transplantation Semin Liv Dis 1987 7: 210–229
Locasciulli A, Alberti A, de Bock R et al. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group-Infectious Diseases Working Party Bone Marrow Transplant 1994 14: 833–837
Locasciulli A, Testa M, Valsecchi MG et al. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study Blood 1997 90: 3799–3805
Ljungman P, Johansson N, Aschan JM et al. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients Blood 1995 86: 1614–1618
Tomás JF, Gómez-Garcia de Soria V, López-Lorenzo JL et al. Autologous or allogeneic bone marrow transplantation for acute myeloblastic leukemia in second complete remission: importance of duration of first complete remission in final outcome Bone Marrow Transplant 1996 17: 979–984
Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia New Engl J Med 1986 314: 729–735
Desmet VJ, Gerber M, Hoofnagle JH et al. Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 1994 19: 1513–1520
Powell EE, Cooksley WG, Hanson R et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 1990 11: 74–80
Johnson PJ, McFarlane IG, Alvarez F et al. Meeting Report. International Autoimmune Hepatitis Group Hepatology 1993 18: 998–1005
Bacon BR, Healey JF, Brittenham GM et al. Hepatic microsomal function in rats with chronic dietary iron overload Gastroenterology 1986 90: 1844–1853
Gualdi R, Casalgrandi G, Montosi G et al. Excess iron into hepatocytes is required for activation of collagen type I during iron experimental siderosis Gastroenterology 1994 107: 1118–1124
Friedman SL . Seminars in medicine of the Beth Israel Hospital, Boston: the cellular basis of hepatic fibrosis New Engl J Med 1993 328: 1828–1835
McKay PJ, Murphy JA, Cameron S et al. Iron overload and liver dysfunction after allogeneic bone marrow transplantation Bone Marrow Transplant 1996 17: 63–66
Harrison P, Neilson JR, Marwah SS et al. Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation J Clin Pathol 1996 49: 853–856
McSween R, Anthoy P, Scheuer P et al. Pathology of the Liver Churchill Livingstone: New York 1994
Faa G, Arrbu R, Nurchi V et al. Sampling variability in hepatic iron concentration in beta-thalassemia Bone Marrow Transplant 1997 19: (Suppl. 2) 173–175
Lucarelli G, Angelucci E, Giardini C et al. Fate of iron stores in thalassemia after bone marrow transplantation Lancet 1993 342: 1388–1391
Muretto P, Del Fiasco S, Angelucci E, Lucarelli G . Bone marrow transplantation in thalassemia: modification of hepatic iron overload and related pathologies after long-term engrafting Liver 1994 14: 14–24
Angelucci E, Muretto P, Lucarelli G et al. and the Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation Blood 1997 90: 994–998
Tomás JF, Pinilla I, Gómez-García de Soria V et al. Long-term liver dysfunction after allogeneic bone marrow transplantation (BMT): importance of hepatitis C virus (HCV) infection and iron overload Blood 1995 86: (Suppl. 1) 856a (Abstr.)
Kolho E, Ruutu P, Ruutu T . Hepatitis C infection in BMT patients Bone Marrow Transplant 1993 11: 119–123
Chen PM, Fan S, Hsieh RK et al. Liver disease in patients with liver dysfunction prior to bone marrow transplantation Bone Marrow Transplant 1992 9: 415–419
Fujii Y, Kaku K, Tanaka M et al. Hepatitis C virus infection and liver disease after allogeneic bone marrow transplantation Bone Marrow Transplant 1994 13: 523–526
Norol F, Roche B, Satin Marc Girardin MF et al. Hepatitis C virus infection and allogeneic bone marrow transplantation Transplantation 1994 57: 393–397
Locasciulli A, Bacigalupo A, VantLint MT et al. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation Bone Marrow Transplant 1995 16: 407–411
Ljungman P, Fassas A, Ferrant A et al. Long-term effects of hepatitis C virus (HCV) infection after bone marrow transplantation Bone Marrow Transplant 1998 21: (Suppl. 1) S152 (Abstr.)
Rodríguez-Íñigo E, Tomás JF, Gómez-García de Soria V et al. Hepatitis C and G virus infection and liver dysfunction after allogeneic bone marrow transplantation: results from a prospective study Blood 1997 90: 1326–1331
Kuo G, Choo QL, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis Science 1989 244: 362–364
Hoofnagle JH . Hepatitis C: the clinical spectrum of disease Hepatology 1997 26: (Suppl. 1) 15S–20S
Strasser SI, Sullivan KM, Myerson D et al. Cirrhosis of the liver in long-term marrow transplant survivors Blood 1999 93: 3259–3266
Strasser SI, Myerson D, Spurgeon CL et al. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up Hepatology 1999 29: 1893–1899
Fried R, Murakami CS, Willson RA et al. Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver Ann Intern Med 1992 116: 624–629
Acknowledgements
This work was supported in part by grant number FIS 97/0157 awarded by the Fondo de Investigaciones Sanitarias de la Seguridad Social of Spain.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tomás, J., Pinilla, I., García-Buey, M. et al. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone Marrow Transplant 26, 649–655 (2000). https://doi.org/10.1038/sj.bmt.1702532
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702532
Keywords
This article is cited by
-
Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation (2016)
-
Komplikationen der allogenen Knochenmark- und Stammzelltransplantation
Der Internist (2014)
-
The management of iron overload in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients: Where do we stand?
Annals of Hematology (2013)
-
Assessing the risk of transplant-related complications and individually tailoring the HSCT procedure in children and adolescents—is it possible?
Bone Marrow Transplantation (2008)
-
The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
Bone Marrow Transplantation (2008)